Literature DB >> 33573155

Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models.

Harald Hundsberger1,2, Anna Stierschneider1, Victoria Sarne1, Doris Ripper1, Jasmin Schimon1, Hans Peter Weitzenböck1, Dominik Schild1, Nico Jacobi3, Andreas Eger1,3, Josef Atzler4, Christian T Klein1, Christoph Wiesner1.   

Abstract

Quercetin, a dietary flavonoid found in fruits and vegetables, has been described as a substance with many anti-cancer properties in a variety of preclinical investigations. In the present study, we demonstrate that 2D and 3D melanoma models exhibit not only different sensitivities to quercetin, but also opposite, cancer-promoting effects when metastatic melanoma spheroids are treated with quercetin. Higher concentrations of quercetin reduce melanoma growth in three tested cell lines, whereas low concentrations induce the opposite effect in metastatic melanoma spheroids but not in the non-metastatic cell line. High (>12.5 µM) or low (<6.3 µM) quercetin concentrations decrease or enhance cell viability, spheroid size, and cell proliferation, respectively. Additionally, melanoma cells cultivated in 2D already show significant caspase 3 activity at very low concentrations (>0.4 µM), whereas in 3D spheroids apoptotic cells, caspase 3 activity can only be detected in concentrations ≥12.5 µM. Further, we show that the tumor promoting or repressing effect in the 3D metastatic melanoma spheroids are likely to be elicited by a precisely controlled regulation of Nrf2/ARE-mediated cytoprotective genes, as well as ERK and NF-κB phosphorylation. According to the results obtained here, further studies are needed to better characterize the mechanisms of action underlying the pro- and anti-carcinogenic effects of quercetin on human melanomas.

Entities:  

Keywords:  3D spheroids; Nrf2 signaling; melanoma; phenotypic drug screening; quercetin

Mesh:

Substances:

Year:  2021        PMID: 33573155      PMCID: PMC7866537          DOI: 10.3390/molecules26030717

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  41 in total

1.  Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden.

Authors:  A M Ekström; M Serafini; O Nyrén; A Wolk; C Bosetti; R Bellocco
Journal:  Ann Oncol       Date:  2010-08-05       Impact factor: 32.976

2.  Disposition of quercetin in man after single oral and intravenous doses.

Authors:  R Gugler; M Leschik; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

3.  Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.

Authors:  Heidi Menrad; Christian Werno; Tobias Schmid; Ekaterini Copanaki; Thomas Deller; Nathalie Dehne; Bernhard Brüne
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

Review 4.  Antioxidants and cancer, part 3: quercetin.

Authors:  D W Lamson; M S Brignall
Journal:  Altern Med Rev       Date:  2000-06

5.  Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase.

Authors:  Thilakavathy Thangasamy; Sivanandane Sittadjody; Susan Lanza-Jacoby; Phyllis R Wachsberger; Kirsten H Limesand; Randy Burd
Journal:  Nutr Cancer       Date:  2007       Impact factor: 2.900

Review 6.  Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents.

Authors:  Hidetomo Kikuchi; Bo Yuan; Xiaomei Hu; Mari Okazaki
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

7.  Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030.

Authors:  Gery P Guy; Cheryll C Thomas; Trevor Thompson; Meg Watson; Greta M Massetti; Lisa C Richardson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-05       Impact factor: 17.586

Review 8.  Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development Strategy.

Authors:  Zoey Harris; Micah G Donovan; Gisele Morais Branco; Kirsten H Limesand; Randy Burd
Journal:  Front Nutr       Date:  2016-10-31

9.  Dietary flavonoids and the risk of colorectal cancer.

Authors:  Evropi Theodoratou; Janet Kyle; Roseanne Cetnarskyj; Susan M Farrington; Albert Tenesa; Rebecca Barnetson; Mary Porteous; Malcolm Dunlop; Harry Campbell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-04       Impact factor: 4.254

10.  Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer.

Authors:  Na Li; Chaoyang Sun; Bo Zhou; Hui Xing; Ding Ma; Gang Chen; Danhui Weng
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more
  1 in total

Review 1.  The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.

Authors:  Mariana Matias; Jacinta O Pinho; Maria João Penetra; Gonçalo Campos; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.